Deferred Tax Assets, Valuation Allowance in USD of Pacira BioSciences, Inc. from Q4 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pacira BioSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2011 to Q4 2024.
  • Pacira BioSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $24.8M, a 2.76% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $24.8M -$704K -2.76% 31 Dec 2024 10-K 27 Feb 2025
Q4 2023 $25.5M +$2.59M +11.3% 31 Dec 2023 10-K 27 Feb 2025
Q4 2022 $22.9M +$3.94M +20.7% 31 Dec 2022 10-K 29 Feb 2024
Q4 2021 $19M +$16.5M +655% 31 Dec 2021 10-K 28 Feb 2023
Q4 2020 $2.52M -$127M -98.1% 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $6.61M +$4.81M +267% 30 Sep 2020 10-Q 30 Oct 2020
Q4 2019 $129M +$10.4M +8.79% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 $1.8M 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $1.8M 30 Jun 2019 10-Q 08 Aug 2019
Q4 2018 $119M -$1.57M -1.31% 31 Dec 2018 10-K 21 Feb 2020
Q4 2017 $120M -$28.5M -19.2% 31 Dec 2017 10-K 28 Feb 2019
Q4 2016 $149M +$16.6M +12.6% 31 Dec 2016 10-K 28 Feb 2018
Q4 2015 $132M +$775K +0.59% 31 Dec 2015 10-K 01 Mar 2017
Q4 2014 $131M +$9.86M +8.11% 31 Dec 2014 10-K 25 Feb 2016
Q4 2013 $121M +$17.5M +16.9% 31 Dec 2013 10-K 24 Feb 2015
Q4 2012 $104M +$20.7M +24.9% 31 Dec 2012 10-K 25 Feb 2014
Q4 2011 $83.2M 31 Dec 2011 10-K 07 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.